HomeNews

News

Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company focused on developing novel drugs for cancer, fibrosis and inflammation, announced that interim clinical data...

Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate

Turn Therapeutics, a biotechnology company developing innovative products for infectious disease, advanced wound care, and dermatology, announced positive in-vivo data for its therapeutic candidate...

Hoth Therapeutics Announces HT-ALZ Therapeutic Shows Cognitive Improvements in Alzheimer’s Disease

Hoth Therapeutics, Inc., a patient-focused biopharmaceutical company, announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimer's disease mouse model (aged APP/PS1+/-...

GenomOncology Selected by Personalis to Support MRD and SNV Analysis for NeXT Personal Assay

GenomOncology announced that the GenomOncology (GO) Pathology Workbench has been selected by Personalis to support its NeXT Personal assay for molecular residual disease (MRD)...

Arcadia Research Data Now Available in AWS Data Exchange

Arcadia, a leading data analytics platform for healthcare and life sciences, announced the availability of Arcadia Research Data through AWS Data Exchange, an Amazon...
0FansLike
0FollowersFollow
spot_img

Hot Topics